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Abstract  The  indications  for  radiofrequency  bone  ablation  in  the  case  of  benign  tumours
(osteoid osteoma,  osteoblastoma)  are  curative,  whereas  for  bone  metastases,  the  prime  aim
is palliative  analgesia.  The  failure  rate  for  osteoid  osteomas  is  low  (<  15%),  and  70  to  90%  of
patients with  metastases  experience  considerable  relief,  but  if  the  treatment  fails,  it  can  be
offered again.  In  the  spine,  heating  can  damage  neighboring  nerve  structures,  which  means
they need  to  be  protected  (CO2 dissection).  Radiofrequency  ablation  may  be  combined  with  an
injection of  cement.  The  osteonecrosis  resulting  from  heating  is  painful  and  justiﬁes  performing
the procedure  under  general  anesthesia.
© 2012  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Pain  can  signiﬁcantly  alter  the  quality  of  life  of  cancer  patients  with  bone  metastases.
The  prognosis  for  these  patients  varies,  related  to  the  origin  of  the  cancer,  with  consider-
able  differences  in  survival  depending  on  the  primary  tumour  —  from  a  few  months  for  a
bronchial  carcinoma  to  several  years  for  a  breast  cancer.
Approximately  one  third  of  patients  are  inadequately  relieved  by  standard  treatments,
which  are  often  associated  with  each  other  and  include  speciﬁc  general  (chemotherapy,
bisphosphonates)  or  local  (surgery,  radiotherapy)  treatments.  In  addition,  analgesic  drug
treatment  may  be  inadequate  or  associated  with  adverse  reactions.  To  combat  recalcitrant
pain,  alternative,  image-guided  therapeutic  methods  have  developed,  particularly  meth-
ods  of  tumour  destruction  based  on  temperature,  such  as  radiofrequency  ablation  (RFA)
and  cryotherapy.  RFA  is  also  widely  used  to  treat  benign  bone  tumours,  namely  osteoid
osteomas.  This  point  will  also  be  developed.
∗ Corresponding author.
E-mail address: palussiere@bergonie.org (J. Palussière).
211-5684/$ — see front matter © 2012 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.
ttp://dx.doi.org/10.1016/j.diii.2012.06.008
G
b
a
p
i
t
m
a
t
i
i
c
t
s
t
f
W
p
t
T
b
o
[
o
l
a
m
i
w
t
u
t
i
p
O
n
t
s
t
I
w
r
m
i
ﬁ
R
a
e
t
o
a
i
I
r
c
e
eRadiofrequency  ablation  of  bone  tumours  
Principles
Radiofrequency  ablation  uses  an  electromagnetic  300  to  500
KHz  frequency  current,  carried  by  an  image-guided  elec-
trode  introduced  into  the  tumour.  Current  phase  changes
induce  local  ionic  agitation,  which  triggers  molecular  fric-
tion  movements  responsible  for  a  rise  in  temperature.
The  temperature  increases  around  the  electrode  and  is
then  distributed  by  diffusion.  The  aim  is  to  subject  the
whole  volume  of  the  tumour  to  be  treated  to  a  temper-
ature  higher  than  70 ◦C  in  order  to  achieve  irreversible
cell  death  by  coagulation  necrosis  of  the  cell  proteins,
tumour  cells  being  no  more  resistant  to  heat  than  normal
cells.
It  has  been  shown  that  when  the  cortical  bone  of  ani-
mals  is  intact,  it  has  such  good  insulating  properties  that  it
is  possible  to  heat  close  to  joint  surfaces  without  damag-
ing  the  cartilage  [1].  It  has  also  been  shown  that  there  is
a  strong  correlation  between  the  size  of  the  area  of  necro-
sis  induced  by  the  heating  measured  macroscopically,  and
the  size  of  the  ablation  area  measured  by  MRI  [2].  When
there  are  metastases,  the  pain,  other  than  from  fractures,
is  caused  by  a  number  of  different  factors  and  mechanisms,
which  are  often  associated:  the  release  of  chemical  medi-
ators  stimulating  bone  and  periosteal  nociceptive  ﬁbres,
mechanical  factors  such  as  an  increase  in  intraosseous  pres-
sure  due  to  the  tumour,  or  stretching  and  distortion  of  the
periosteum,  reactive  muscle  contractions,  inﬁltration  and
nerve  compression  causing  neuropathic  pain,  etc.  The  pain
is  felt  as  background  pain  combined  with  spikes  of  break-
through  pain;  it  is  not  necessarily  related  to  the  degree  of
metastatic  destruction.  The  heating  induced  by  RFA  does
not  produce  consolidation  but  acts  on  the  nerve  endings  and
helps  curb  the  volume  of  the  tumour.
To  treat  these  metastases,  there  are  straight  elec-
trodes  and  electrodes  with  deployable  tines.  The  equipment
used  varies  depending  on  the  amount  of  bone  destruction
required:  deployable  electrodes  certainly  need  sufﬁcient
tumour  tissue  volume  to  be  opened  and  are  impossible  to
use  in  osteoblastic  metastases.
Technique
In  practice,  the  procedure  is  performed  under  CT  or  ﬂat-
panel  detector  guidance.  The  latter  method  uses  software
to  help  positioning;  the  procedure  can  be  performed  under
radioscopy,  while  still  having  access  to  slice  reconstructions.
Hygiene  rules  need  to  be  the  same  as  for  surgery  in  order
to  avoid  any  problem  of  infection,  and  the  procedure  is
performed  under  general  anesthesia  because  RF  ablation
is  painful.  If  the  cortical  bone  is  preserved,  it  is  drilled  in
advance  with  an  11  or  13  G  trocar  to  prepare  the  path  for  the
electrode  (case  no 1,  Fig.  1a—d).  If  the  trocar  is  not  insulated
it  must  be  withdrawn  before  the  electrode  is  introduced,  so
as  to  avoid  any  burning  along  the  pathway.Indications and results
Radiofrequency  ablation  of  bone  metastases  can  be  used
alone  or  associated  with  stabilization  by  cementoplasty.
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angi  has  proposed  a  decisional  algorithm  [3,4]. For  all  the
ones  subjected  to  mechanical  compression  stresses,  such
s  the  vertebrae  or  acetabula,  stabilization  by  cemento-
lasty  is  a  priority  and  is  often  sufﬁcient.  RFA  is  offered
f  there  is  periosseous  extension  of  the  tumour,  in  order
o  reduce  tumour  volume,  or  in  the  case  of  an  isolated
etastasis,  or  one  evolving  slowly,  which  then  requires  local
ntitumour  treatment  that  is  as  complete  as  possible.  For
he  ﬂat  bones  of  the  rib  cage  (case  no 2,  Fig.  2a—c),  the
liac  wings,  the  superior  pubic  or  ischiopubic  rami,  RFA  is
ndicated  in  as  far  as  the  mechanical  stabilizing  effect  of
ementoplasty  is  less  necessary.  Few  studies  have  evaluated
he  radiofrequency  ablation  of  metastatic  bone  lesions.  In  a
tudy  [5],  in  55  patients,  RFA  produced  a  signiﬁcant  reduc-
ion  in  pain,  and  a  signiﬁcant  improvement  in  the  relief
elt  and  in  mood,  all  assessed  at  one  and  three  months.
hen  the  patients’  least  intense  pain  before  RFA  was  com-
ared  with  the  same  at  three  months  after  the  treatment,
he  Odds  ratio  was  eight  (95%  CI,  0.9—15.2;  P  <  0.001).
hree  patients  presented  grade  III  toxicity.  Another  feasi-
ility  study  in  12  patients  conﬁrmed  the  analgesic  efﬁcacy
f  the  technique  with  an  absence  of  serious  complication
6].  A  multicentre  trial  evaluated  RFA  in  a  larger  cohort
f  43  patients  who  had  painful,  refractory,  pelvic  or  sacral
esions  of  between  1  and  18  cm  in  size  [7].  With  assessments
t  4,  12  and  24  weeks,  95%  of  them  described  improve-
ent  in  their  pain  (a  fall  of  at  least  two  points  in  the  most
ntense  pain);  a  reduction  in  the  consumption  of  analgesics
as  also  shown  at  8  and  12  weeks.  Three  incidents  need
o  be  mentioned:  a  cutaneous  burn,  transitory  faecal  and
rinary  incontinence  following  treatment  of  a  sacral  loca-
ion,  and  an  ace  tabular  fracture.  One  of  the  advantages
s  being  able  to  reapply  the  treatment  if  the  pain  reap-
ears:  there  is  no  dose-related  limitation  as  in  radiotherapy.
steoblastic  metastases  are  a  good  indication  for  the  tech-
ique.
Evaluating  the  relief  provided  is  sometimes  difﬁcult  in
hese  patients,  because  other  bone  metastases  may  become
ymptomatic.  A  prospective  study  is  underway  ﬁnanced  by
he  French  Hospital  Clinical  Research  Programme  (PHRC).
ts  objective  is  to  determine  the  analgesic  efﬁcacy  at  eight
eeks  following  RF  ablation  of  painful  bone  metastases
efractory  to  radiotherapy,  bisphosphonates  and  properly
anaged  analgesic  opioid  treatment.  An  osteoid  osteoma
s  a  small,  benign,  intracortical  bone  tumour,  and  was  the
rst  type  of  bone  tumour  treated  by  thermal  ablation  [8,9].
FA  is  close  to  90%  effective  in  dealing  with  the  symptoms
ssociated  with  this  type  of  tumour,  and  because  of  the
ase  and  efﬁcacy  of  thermal  ablation  procedures  (RF,  laser),
hey  have  ousted  surgery.  A  typical  intracortical  osteoid
steoma  is  less  than  20  mm  and  appears  as  a  lacuna  (nidus)
ssociated  with  cortical  osteosclerosis.  It  ﬁxes  the  tracer
n  scintigraphy  and  perilesional  edema  is  visible  with  MRI.
t  is  not  imperative  to  perform  a  biopsy  [10]; this  should
ather  be  reserved  for  atypical  lesions  [11]. However,  in
hildren  or  young  adults,  it  is  better  to  have  histological
vidence  conﬁrming  the  benign  character  of  the  lesion,
specially  since  the  biopsy  does  not  lengthen  or  compli-
ate  the  procedure.  During  the  procedure,  the  route  to  be
aken  by  the  electrode  for  insertion  into  the  nidus  needs
o  be  prepared  by  drilling  the  cortical  bone.  If  the  osteoid
steoma  is  located  near  the  skin  (in  the  anterior  surface
682  J.  Palussière  et  al.
Figure 1. a, b: insertion of the bone biopsy trocar (11G coaxial system); c: biopsy path; d: position of the electrode in the biopsy path
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istraight electrode with a 7 mm active tip).
f  the  tibia,  the  radius,  etc.),  it  is  desirable  to  cool  the
kin  to  avoid  burning.  Follow-up  imaging  will  show  com-
lete  ossiﬁcation  or  a  residual  nidus.  Recurrence,  often  due
o  incorrect  positioning  of  the  electrode,  can  be  retreated
11].
omplications
ne  of  the  problems  of  bone  radiofrequency  ablation  is  the
otential  risk  of  causing  damage  to  nerves  near  the  bone
tructures.  It  has  been  demonstrated  in  animal  studies  that
he  temperature  of  soft  tissue  adjacent  to  the  radiofre-
uency  ablation  site  depends  on  the  thickness  of  the  cortical
one,  the  distance  relative  to  the  periosteum  and  the  dura-
ion  of  the  radiofrequency  treatment  [12]. In  order  to  avoid
amaging  nerve  structures,  maintaining  a  safety  distance
f  10  mm  is  recommended  between  the  periosteum  and  the
earest  nerve  structure  when  the  thickness  of  cortical  bone
b
o
a
wetween  the  electrode  and  the  periosteum  is  less  than  5 mm
13].  With  bone  metastases,  it  is  obviously  necessary  to  bear
n  mind  that  the  cortical  bone  is  often  pathological  and  con-
equently  its  effect  as  an  insulator  is  limited,  with  the  risk
f  the  area  of  thermal  ablation  extending  into  periosseous
egions.
The  risk  of  neurological  damage  due  to  a  thermal  lesion
s  greatest  in  the  spine.  If  the  lesion  to  be  treated  is  too
lose  (less  than  10  mm)  to  a  neurological  structure  (the
pinal  cord,  a  nerve  root)  there  is  a  risk  of  the  heat  causing
rreversible  damage.  A  thermocouple  must  be  positioned  in
ontact  with  the  organ  to  be  protected,  in  order  to  check
he  temperature  during  the  procedure,  and  this  organ  sepa-
ated  from  the  area  of  thermal  ablation.  This  is  possible  by
njecting  a  non-ionic  solution  or  CO2 to  create  an  adequate
arrier  between  the  area  to  be  heated  and  the  neighboring
rgan  [14,15]. CO2 is  practical  and  easy  to  use  [16]. There
re  but  a  few  other  complications  related  to  this  technique
hen  applied  to  bone:
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Figure 2. a: painful metastasis of a breast cancer, poorly relieved by level three analgesics; b, c: radiofrequency ablation: straight
 almost complete (at 1 year).
TAKE-HOME  MESSAGES
• Radiofrequency  ablation  is  very  effective  for  benign
bone  tumours  (osteoid  osteomas).
• RFA  treatment  of  bone  metastases  provides  relief  to
the  majority  of  patients.
• If  the  analgesia  obtained  is  inadequate,
radiofrequency  treatment  can  be  repeated.
• For  the  spine  and  acetabulum,  radiofrequency
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Celectrode with a 2 cm active tip in place. Efﬁcacy for relieving pain
• considerable  increase  in  pain  may  occur  immediately
following  the  procedure,  related  to  the  brutal  necrosis
caused  by  the  heat.  This  risk  justiﬁes  the  proce-
dure  being  performed  under  general  anesthesia  and
makes  close  analgesic  monitoring  in  the  ﬁrst  few  hours
essential;
• a  cutaneous  burn  can  occur  at  the  patient  return
electrodes;  this  problem  arises  when  exposure  to  the
radiofrequency  current  is  prolonged  (>  20  minutes)  and
when  the  power  delivered  is  considerable  (>  150  W).  These
conditions  are  rarely  met  during  radiofrequency  ablation
of  bone  tissue.  To  decrease  this  risk,  simply  watch  the
temperature  during  the  procedure  at  the  grounding  pads
placed  on  the  patient’s  thighs;
• infection  of  the  focus  being  treated  is  a  possible  risk  but
should  be  avoidable  if  surgery  hygiene  and  asepsis  mea-
sures  are  observed.
Conclusion
The  decision  must  be  multidisciplinary,  taken  together  by
the  interventional  radiologist,  the  radiotherapist,  the  pain
specialist,  the  medical  oncologist  and  the  surgeon.  The
results  of  RFA  are  excellent  for  treatment  of  osteoid  osteo-
mas.
P
e
a
pablation  can  be  associated  with  cementoplasty.
linical case
ase no 1
steoid  osteoma  of  the  lesser  trochanter  treated  by  RFA
Fig.  1).
ase no 2ainful  sternal  metastasis  of  a  breast  cancer  (Fig.  2a)  inad-
quately  relieved  by  level  three  analgesics;  radiofrequency
blation  (Fig.  2b  and  c)  almost  completely  effective  on  the
ain  (at  one  year).
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